Ketamine Interleaved With Electroconvulsive Therapy for Depression
Status:
Terminated
Trial end date:
2020-06-03
Target enrollment:
Participant gender:
Summary
Pragmatic, randomised, controlled, parallel group, pilot clinical trial of ketamine vs.
midazolam interleaved with electroconvulsive therapy (ECT) as an adjunctive treatment for a
major depressive episode. The main purpose of the pilot study is to assess trial processes to
help inform a future definitive trial.